Keyphrases
Acute Myeloid Leukemia
15%
Adenoviral Vector
12%
Adenovirus
27%
Alzheimer's Disease
52%
Apolipoprotein E
14%
Apoptosis
22%
Astrocytes
13%
B Cells
23%
Bone Marrow
14%
Breast Cancer
19%
CD4+ T Cells
11%
CD8+ T Cells
21%
Cell Death
14%
Central Nervous System
27%
Cerebrospinal Fluid
22%
Chemotherapy
18%
Clinical Outcomes
14%
Clinical Trials
24%
Confidence Interval
27%
COVID-19
29%
Dendritic Cells
37%
Diabetes
15%
Disease Progression
11%
Elastin
14%
Endothelial Cells
12%
Epitope
13%
Escherichia Coli
15%
Gene Expression
33%
Gene Therapy
19%
Gene-deficient Mice
16%
Granulocyte Colony-stimulating Factor (G-CSF)
19%
Hazard Ratio
11%
Heart Failure
13%
Hematopoietic Stem Cells
19%
Human Immunodeficiency Virus Type 1 (HIV-1)
15%
Immune Cells
11%
Immune Response
27%
Immune System
14%
In Cancer
17%
Inflammation
34%
Inflammatory Response
11%
Innate Immune Response
14%
Integrin
14%
Interferon-α (IFN-α)
26%
Interleukin-1β
18%
Knock-in Mouse Model
14%
Leishmania
12%
Liver
20%
Lung
21%
Lymph Node
12%
Lymphocytes
15%
Macrophages
55%
Metabolism
11%
MHC Class II
14%
Microglia
16%
Monoclonal Antibody
26%
Monocytes
16%
Mouse Model
36%
Multiple Myeloma
11%
Multiple Sclerosis
19%
Murine Model
17%
Natural Killer Cells
40%
Neurodegeneration
13%
Neurofibromatosis Type 1 (NF-1)
29%
Neurofibromatosis Type I
19%
Neutrophils
21%
NF-B
12%
Non-small Cell Lung Cancer (NSCLC)
15%
Obesity
16%
Odds Ratio
12%
Older Adults
17%
Osteoclast
19%
Ovarian Cancer
12%
Overall Survival
25%
Overexpression
17%
Phase II Study
11%
Phosphorylation
13%
Placebo
11%
Positron Emission Tomography
16%
Radiation Therapy
13%
Recombinant
13%
Resection
14%
Risk Factors
15%
Sepsis
18%
Signaling Pathway
13%
T Cell Activation
13%
T Cell Receptor
12%
T Cells
72%
Toxoplasma Gondii (T. gondii)
21%
Transcription Factor
22%
Transgenic Mice
15%
Tumor
79%
Tumor Cells
21%
Tumor Necrosis Factor-α
21%
United States
13%
Viral
12%
Viral Infection
14%
Virulence
12%
Virus
37%
West Nile Virus
13%
Medicine and Dentistry
Acute Myeloid Leukemia
9%
Adenoviridae
11%
Adenovirus Vector
7%
Adverse Event
9%
Alzheimer's Disease
23%
Amyloid Protein
11%
Apoplexy
8%
Arm
8%
B Cell
12%
Biological Marker
23%
Breast Cancer
29%
Cancer
23%
Cancer Cell
13%
Cell Death
8%
Cell Signaling Pathway
8%
Central Nervous System
9%
Cerebrospinal Fluid
11%
Clear Cell Renal Cell Carcinoma
8%
Clinical Trial
22%
Computer Assisted Tomography
8%
Congestive Heart Failure
15%
Connective Tissue Cancer
9%
COVID-19
15%
Cytokine
14%
Dendritic Cell
8%
Diabetes
13%
Diagnosis
14%
Diseases
77%
Endothelial Cell
9%
Fluorodeoxyglucose F 18
9%
Ganglioglioma
14%
Gene Expression
16%
Gene Therapy
11%
Glioblastoma
9%
Gut
8%
Hazard Ratio
9%
Hematopoietic Cell
14%
Homeostasis
9%
Human Immunodeficiency Virus
13%
Immune Response
11%
Immunity
15%
Immunotherapy
12%
In Vitro
27%
Infection
39%
Injury
8%
Lung
19%
Lung Cancer
10%
Lung Transplantation
8%
Lymph Node
10%
Lymphocyte
12%
Macrophage
22%
Magnetic Resonance Imaging
15%
Malignant Neoplasm
40%
Melanoma
10%
Messenger RNA
13%
Metastatic Carcinoma
17%
Microglia
9%
Multiple Myeloma
8%
Neoplasm
100%
Neurofibromatosis Type I
20%
Neutrophil
9%
Non Small Cell Lung Cancer
13%
Odds Ratio
10%
Oncology
8%
Osteoarthritis
8%
Osteoclast
9%
Ovarian Cancer
14%
Overall Survival
24%
Pancreas Cancer
7%
Pathogen
8%
Pediatrics
16%
Placebo
8%
Platelet
7%
Polyethylene Terephthalate
11%
Positron Emission Tomography
19%
Positron Emission Tomography-Computed Tomography
12%
Premature Labor
8%
Prevalence
9%
Programmed Cell Death
17%
Progression Free Survival
8%
Promoter Region
10%
Prostate Cancer
8%
Quality of Life
8%
Radiation Therapy
21%
Receptor
26%
Recurrent Disease
18%
Sepsis
12%
Serositis
9%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Small Intestine Resection
8%
Stem Cell
9%
Surgeon
9%
Surgery
37%
T Cell
27%
Targeted Therapy
8%
Transplantation
9%
Tumor Cell
12%
Tumor Necrosis Factor
14%
Tumor Progression
10%
Virus
11%